Roberto Gorla

2.5k total citations
63 papers, 1.6k citations indexed

About

Roberto Gorla is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Roberto Gorla has authored 63 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Rheumatology, 20 papers in Immunology and 18 papers in Genetics. Recurrent topics in Roberto Gorla's work include Rheumatoid Arthritis Research and Therapies (37 papers), Systemic Lupus Erythematosus Research (23 papers) and Chronic Lymphocytic Leukemia Research (18 papers). Roberto Gorla is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (37 papers), Systemic Lupus Erythematosus Research (23 papers) and Chronic Lymphocytic Leukemia Research (18 papers). Roberto Gorla collaborates with scholars based in Italy, United States and Spain. Roberto Gorla's co-authors include Fabiola Atzeni, Ennio Giulio Favalli, Piercarlo Sarzi‐Puttini, Roberto Caporali, Antonio Marchesoni, Francesca Bobbio‐Pallavicini, Luisa Imberti, Daniélé Primi, Roberto Cattaneo and Chiara Bazzani and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and The Journal of Infectious Diseases.

In The Last Decade

Roberto Gorla

62 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Gorla Italy 22 963 596 386 239 209 63 1.6k
P. Duffau France 25 652 0.7× 794 1.3× 195 0.5× 181 0.8× 124 0.6× 103 1.9k
Evelyne T. Edwards United States 5 885 0.9× 606 1.0× 400 1.0× 177 0.7× 105 0.5× 6 1.9k
Karyl S. Barron United States 26 732 0.8× 978 1.6× 600 1.6× 104 0.4× 107 0.5× 56 2.6k
Alessandra Vultaggio Italy 32 512 0.5× 1.1k 1.9× 161 0.4× 174 0.7× 368 1.8× 124 2.9k
Karen Onel United States 27 964 1.0× 591 1.0× 999 2.6× 71 0.3× 112 0.5× 79 2.1k
Claiton Viegas Brenol Brazil 22 774 0.8× 330 0.6× 430 1.1× 122 0.5× 52 0.2× 94 1.3k
Syuji Takei Japan 26 1.2k 1.2× 750 1.3× 1.2k 3.2× 190 0.8× 95 0.5× 108 2.7k
Kohei Nagasawa Japan 24 371 0.4× 891 1.5× 327 0.8× 111 0.5× 113 0.5× 86 1.7k
Marc Schmalzing Germany 22 524 0.5× 420 0.7× 359 0.9× 133 0.6× 98 0.5× 125 1.6k
Santiago Muñoz‐Fernández Spain 27 1.2k 1.2× 463 0.8× 474 1.2× 52 0.2× 124 0.6× 75 1.8k

Countries citing papers authored by Roberto Gorla

Since Specialization
Citations

This map shows the geographic impact of Roberto Gorla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Gorla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Gorla more than expected).

Fields of papers citing papers by Roberto Gorla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Gorla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Gorla. The network helps show where Roberto Gorla may publish in the future.

Co-authorship network of co-authors of Roberto Gorla

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Gorla. A scholar is included among the top collaborators of Roberto Gorla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Gorla. Roberto Gorla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerardi, Maria Chiara, Francesca Crisafulli, Chiara Bazzani, et al.. (2022). Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis. Frontiers in Pharmacology. 13. 887462–887462. 15 indexed citations
2.
Ravasio, Roberto, Giampiero Girolomoni, & Roberto Gorla. (2018). Analisi di budget impact del biosimilare di etanercept: lo scenario italiano. Global & Regional Health Technology Assessment. 5(1). 1 indexed citations
3.
Manara, M., Roberto Caporali, Ennio Giulio Favalli, et al.. (2017). Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry.. PubMed. 35(5). 804–809. 21 indexed citations
4.
Iannone, Florenzo, Gianfranco Ferraccioli, L. Sinigaglia, et al.. (2017). Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics’ register GISEA. Clinical Rheumatology. 37(2). 315–321. 36 indexed citations
5.
Atzeni, Fabiola, Sara Bongiovanni, Antonio Marchesoni, et al.. (2013). Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores. Joint Bone Spine. 81(1). 37–40. 23 indexed citations
6.
Gremese, Elisa, Antonio Carletto, Melissa Padovan, et al.. (2012). Obesity and reduction of the response rate to anti–tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine. Arthritis Care & Research. 65(1). 94–100. 157 indexed citations
7.
Atzeni, Fabiola, Piercarlo Sarzi‐Puttini, Roberto Gorla, Antonio Marchesoni, & Roberto Caporali. (2011). Switching rheumatoid arthritis treatments: An update. Autoimmunity Reviews. 10(7). 397–403. 28 indexed citations
8.
Cavazzana, Ilaria, Franco Franceschini, E Danieli, et al.. (2011). Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies. Reumatismo. 57(4). 267–72.
9.
Caporali, Roberto, Piercarlo Sarzi‐Puttini, Fabiola Atzeni, et al.. (2010). Switching TNF-alpha antagonists in rheumatoid arthritis: The experience of the LORHEN registry. Autoimmunity Reviews. 9(6). 465–469. 37 indexed citations
10.
Bazzani, Chiara, Véronique Ramoni, Rossana Scrivo, et al.. (2010). Pregnancy outcomes in women exposed to biologic treatment and affected by chronic arthritis. Annals of the Rheumatic Diseases. 69. 678–678. 2 indexed citations
11.
Bobbio‐Pallavicini, Francesca, Roberto Caporali, Piercarlo Sarzi‐Puttini, et al.. (2009). Tumour necrosis factor antagonist therapy and cancer development: Analysis of the LORHEN registry. Autoimmunity Reviews. 9(3). 175–180. 67 indexed citations
12.
Atzeni, Fabiola, M. Antivalle, Francesca Bobbio‐Pallavicini, et al.. (2009). Predicting response to anti-TNF treatment in rheumatoid arthritis patients. Autoimmunity Reviews. 8(5). 431–437. 44 indexed citations
13.
Marchesoni, Antonio, Eleonora Zaccara, Roberto Gorla, et al.. (2009). TNF‐α Antagonist Survival Rate in a Cohort of Rheumatoid Arthritis Patients Observed under Conditions of Standard Clinical Practice. Annals of the New York Academy of Sciences. 1173(1). 837–846. 128 indexed citations
14.
Bazzani, Chiara, Roberto Caporali, Francesca Bobbio‐Pallavicini, et al.. (2008). Anti-TNFα therapy in a cohort of rheumatoid arthritis patients: Clinical outcomes. Autoimmunity Reviews. 8(3). 260–265. 36 indexed citations
15.
Motta, Mario, Anǵela Tincani, Andrea Lojacono, et al.. (2004). Neonatal outcome in patients with rheumatic disease. Lupus. 13(9). 718–723. 16 indexed citations
16.
Gorla, Roberto, Luisa Imberti, Duilio Brugnoni, et al.. (1994). Differential Priming to Programmed Cell Death of Superantigen-Reactive Lymphocytes of HIV Patients. AIDS Research and Human Retroviruses. 10(9). 1097–1103. 6 indexed citations
17.
Caruso, Arnaldo, Stefano Licenziati, L. Peroni, et al.. (1994). Expression of CD28 on CD8+ and CD4+ Lymphocytes During HIV Infection. Scandinavian Journal of Immunology. 40(5). 485–490. 46 indexed citations
18.
Sottini, Alessandra, Luisa Imberti, Roberto Gorla, Roberto Cattaneo, & Daniélé Primi. (1991). Restricted expression of T cell receptor Vβ but not Vα genes in rheumatoid arthritis. European Journal of Immunology. 21(2). 461–466. 172 indexed citations
19.
Rossi, Giuseppe, Roberto Gorla, Franco Franceschini, et al.. (1990). Prevalence, Clinical, and Laboratory Features of Thrombocytopenia Among HIV-Infected Individuals. AIDS Research and Human Retroviruses. 6(2). 261–269. 35 indexed citations
20.
Gorla, Roberto, et al.. (1990). Decreased number of peripheral blood CD4 + CD29+ lymphocytes and increased in vitro spontaneous production of anti-DNA antibodies in patients with active systemic lupus erythematosus.. Institutional Research Information System (Università degli Studi di Brescia). 17(8). 1048–53. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Duffau Breakdown of academic impact, for papers by Evelyne T. Edwards Breakdown of academic impact, for papers by Karyl S. Barron Breakdown of academic impact, for papers by Alessandra Vultaggio Breakdown of academic impact, for papers by Karen Onel Breakdown of academic impact, for papers by Claiton Viegas Brenol Breakdown of academic impact, for papers by Syuji Takei Breakdown of academic impact, for papers by Kohei Nagasawa Breakdown of academic impact, for papers by Marc Schmalzing Breakdown of academic impact, for papers by Santiago Muñoz‐Fernández
Rankless by CCL
2026